Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.3857 | 0.6976 | 0.6985 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.314 | 0.4641 | 0.5267 |
Echinococcus multilocularis | bile acid beta glucosidase | 0.3857 | 0.6976 | 0.6985 |
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.3857 | 0.6976 | 0.6985 |
Loa Loa (eye worm) | hypothetical protein | 0.2603 | 0.2894 | 0.023 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.4785 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Onchocerca volvulus | Ceramide glucosyltransferase homolog | 0.442 | 0.881 | 1 |
Echinococcus granulosus | non lysosomal glucosylceramidase | 0.3857 | 0.6976 | 0.6985 |
Brugia malayi | Ceramide glucosyltransferase | 0.442 | 0.881 | 0.8364 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.3309 | 0.5191 | 0.1027 |
Echinococcus multilocularis | ceramide glucosyltransferase | 0.442 | 0.881 | 1 |
Loa Loa (eye worm) | ceramide glucosyltransferase | 0.442 | 0.881 | 0.8364 |
Echinococcus granulosus | bile acid beta glucosidase | 0.3857 | 0.6976 | 0.6985 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.442 | 0.881 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.3309 | 0.5191 | 0.1027 |
Echinococcus multilocularis | non lysosomal glucosylceramidase | 0.3857 | 0.6976 | 0.6985 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.4785 | 1 | 1 |
Echinococcus granulosus | ceramide glucosyltransferase | 0.442 | 0.881 | 1 |
Giardia lamblia | Ceramide glucosyltransferase | 0.2004 | 0.0941 | 0.5 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.442 | 0.881 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.